Supplementary Data from Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

Xiuning Le,Hiroshi Sakai,Enriqueta Felip,Remi Veillon, Marina Chiara Garassino,Jo Raskin, Alexis B. Cortot, Santiago Viteri,Julien Mazieres,Egbert F. Smit,Michael Thomas,Wade T. Iams,Byoung Chul Cho,Hye Ryun Kim,James Chih-Hsin Yang,Yuh-Min Chen,Jyoti D. Patel,Christine M. Bestvina,Keunchil Park,Frank Griesinger, Melissa Johnson,Maya Gottfried,Christian Britschgi,John Heymach, Elif Sikoglu,Karin Berghoff,Karl-Maria Schumacher,Rolf Bruns,Gordon Otto,Paul K. Paik

crossref（2023）

Cited 0|Views36

No score

Abstract

Supplementary Data from Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined